Published in Vaccine on December 08, 2003
Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis (2010) 2.45
A Multi-country Study of the Household Willingness-to-Pay for Dengue Vaccines: Household Surveys in Vietnam, Thailand, and Colombia. PLoS Negl Trop Dis (2015) 2.16
Health economics of dengue: a systematic literature review and expert panel's assessment. Am J Trop Med Hyg (2011) 2.05
Dengue incidence in urban and rural Cambodia: results from population-based active fever surveillance, 2006-2008. PLoS Negl Trop Dis (2010) 1.98
Lessons from malaria control to help meet the rising challenge of dengue. Lancet Infect Dis (2012) 1.54
Phylogeography of recently emerged DENV-2 in southern Viet Nam. PLoS Negl Trop Dis (2010) 1.52
Community and school-based health education for dengue control in rural Cambodia: a process evaluation. PLoS Negl Trop Dis (2007) 1.06
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants. Am J Trop Med Hyg (2011) 1.06
Public acceptance and willingness-to-pay for a future dengue vaccine: a community-based survey in Bandung, Indonesia. PLoS Negl Trop Dis (2013) 1.02
Dengue infection in children in Ratchaburi, Thailand: a cohort study. II. Clinical manifestations. PLoS Negl Trop Dis (2012) 1.01
Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys. Antimicrob Agents Chemother (2005) 0.97
Dengue vaccines: recent developments, ongoing challenges and current candidates. Expert Rev Vaccines (2013) 0.94
Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders. PLoS Negl Trop Dis (2013) 0.91
Forecasting dengue vaccine demand in disease endemic and non-endemic countries. Hum Vaccin (2010) 0.87
Disease Burden of Dengue in the Philippines: Adjusting for Underreporting by Comparing Active and Passive Dengue Surveillance in Punta Princesa, Cebu City. Am J Trop Med Hyg (2017) 0.75
Prevention and Control Strategies to Counter Dengue Virus Infection. Front Cell Infect Microbiol (2017) 0.75
Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet (2010) 8.52
Evidence for several waves of global transmission in the seventh cholera pandemic. Nature (2011) 5.62
A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med (2009) 4.84
Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis. Lancet (2005) 4.16
A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ (2008) 4.11
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet (2009) 3.97
Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med (2005) 3.68
5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial. Lancet Infect Dis (2013) 2.82
Antimicrobial drug resistance of Salmonella enterica serovar typhi in asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother (2007) 2.73
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis (2012) 2.70
Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam. J Health Popul Nutr (2003) 2.60
Long-term effectiveness against cholera of oral killed whole-cell vaccine produced in Vietnam. Vaccine (2006) 2.49
The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis (2008) 2.36
Controlling endemic cholera with oral vaccines. PLoS Med (2007) 2.21
Simultaneous inferences on the contrast of two hazard functions with censored observations. Biometrics (2002) 2.18
Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis (2012) 2.18
Cholera outbreaks caused by an altered Vibrio cholerae O1 El Tor biotype strain producing classical cholera toxin B in Vietnam in 2007 to 2008. J Clin Microbiol (2009) 2.16
The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance. BMC Infect Dis (2005) 2.10
Developing the next generation of vaccinologists. Vaccine (2010) 2.07
Detection of Shigella by a PCR assay targeting the ipaH gene suggests increased prevalence of shigellosis in Nha Trang, Vietnam. J Clin Microbiol (2004) 1.98
Salmonella paratyphi A rates, Asia. Emerg Infect Dis (2005) 1.94
Trend and disease burden of bacillary dysentery in China (1991-2000). Bull World Health Organ (2006) 1.93
The future of dengue vaccines. Lancet (2002) 1.90
Use of oral cholera vaccines in an outbreak in Vietnam: a case control study. PLoS Negl Trop Dis (2011) 1.89
Policymakers' views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine (2005) 1.88
Genomic analysis of the Mozambique strain of Vibrio cholerae O1 reveals the origin of El Tor strains carrying classical CTX prophage. Proc Natl Acad Sci U S A (2007) 1.84
Invasive salmonellosis among children admitted to a rural Tanzanian hospital and a comparison with previous studies. PLoS One (2010) 1.81
Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial. PLoS Negl Trop Dis (2011) 1.73
The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis (2011) 1.70
A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. PLoS One (2008) 1.57
High disease burden of diarrhea due to enterotoxigenic Escherichia coli among rural Egyptian infants and young children. J Clin Microbiol (2003) 1.55
Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population. BMC Infect Dis (2006) 1.53
Factors associated with reported diarrhoea episodes and treatment-seeking in an urban slum of Kolkata, India. J Health Popul Nutr (2004) 1.53
Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Vaccine (2005) 1.50
Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt. J Clin Microbiol (2004) 1.46
Pandemic serovars (O3:K6 and O4:K68) of Vibrio parahaemolyticus associated with diarrhea in Mozambique: spread of the pandemic into the African continent. J Clin Microbiol (2005) 1.46
Multilocus sequence typing (MLST) analysis of Vibrio cholerae O1 El Tor isolates from Mozambique that harbour the classical CTX prophage. J Med Microbiol (2006) 1.44
Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine (2006) 1.43
Multilocus variable-number tandem repeat analysis of Vibrio cholerae O1 El Tor strains harbouring classical toxin B. J Med Microbiol (2010) 1.42
The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia. J Health Popul Nutr (2004) 1.40
Evaluation of new-generation serologic tests for the diagnosis of typhoid fever: data from a community-based surveillance in Calcutta, India. Diagn Microbiol Infect Dis (2006) 1.40
Paperless registration during survey enumerations and large oral cholera mass vaccination in Zanzibar, the United Republic of Tanzania. Bull World Health Organ (2010) 1.38
Decreasing incidence of severe malaria and community-acquired bacteraemia among hospitalized children in Muheza, north-eastern Tanzania, 2006-2010. Malar J (2011) 1.37
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen. J Infect Dis (2004) 1.36
Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis (2011) 1.33
Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants. Vaccine (2006) 1.31
The burden of invasive bacterial infections in Pemba, Zanzibar. PLoS One (2012) 1.30
Shigellosis : challenges & management issues. Indian J Med Res (2004) 1.29
Comparisons of predictors for typhoid and paratyphoid fever in Kolkata, India. BMC Public Health (2007) 1.26
The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study. Trans R Soc Trop Med Hyg (2006) 1.25
Replacing paper data collection forms with electronic data entry in the field: findings from a study of community-acquired bloodstream infections in Pemba, Zanzibar. BMC Res Notes (2012) 1.24
Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh. Vaccine (2013) 1.23
Evaluation of the Widal tube agglutination test for the diagnosis of typhoid fever among children admitted to a rural hdospital in Tanzania and a comparison with previous studies. BMC Infect Dis (2010) 1.22
A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design. Trop Med Int Health (2005) 1.22
Organizational aspects and implementation of data systems in large-scale epidemiological studies in less developed countries. BMC Public Health (2006) 1.21
Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy. PLoS Negl Trop Dis (2012) 1.21
Typhoid vaccination: the Asian experience. Expert Rev Vaccines (2008) 1.19
Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity. Int J Epidemiol (2006) 1.19
Cholera vaccines for the developing world. Hum Vaccin (2007) 1.19
Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh. J Infect Dis (2005) 1.19
Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy. J Health Popul Nutr (2004) 1.18
Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis (2003) 1.18
Private demand for cholera vaccines in Beira, Mozambique. Vaccine (2006) 1.15
Reliability of maternal recall and reporting of child births and deaths in rural Egypt. Paediatr Perinat Epidemiol (2003) 1.13
A national cholera vaccine stockpile--a new humanitarian and diplomatic resource. N Engl J Med (2010) 1.13
Treatment of Ebola. N Engl J Med (2015) 1.12
Assessment and comparative analysis of a rapid diagnostic test (Tubex®) for the diagnosis of typhoid fever among hospitalized children in rural Tanzania. BMC Infect Dis (2011) 1.11
Oral vaccines against cholera. Clin Infect Dis (2011) 1.11
A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med (2006) 1.11
The introduction of new vaccines into developing countries. IV: Global Access Strategies. Vaccine (2007) 1.11
Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China. Bull World Health Organ (2003) 1.10
Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India. Antimicrob Agents Chemother (2005) 1.09
Surveillance of pneumococcal-associated disease among hospitalized children in Khanh Hoa Province, Vietnam. Clin Infect Dis (2009) 1.09
Emergence of highly fluoroquinolone-resistant Salmonella enterica serovar Typhi in a community-based fever surveillance from Kolkata, India. Int J Antimicrob Agents (2008) 1.09
Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea. J Infect Dis (2005) 1.08
Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg (2007) 1.06
Use of verbal autopsy to determine mortality patterns in an urban slum in Kolkata, India. Bull World Health Organ (2010) 1.06
Evaluation of a rapid dipstick (Crystal VC) for the diagnosis of cholera in Zanzibar and a comparison with previous studies. PLoS One (2012) 1.06
Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial. Bull World Health Organ (2006) 1.05
Multilocus sequence typing analysis of Shigella flexneri isolates collected in Asian countries. J Med Microbiol (2007) 1.05
Efficacy calculation in randomized trials: global or local measures? Health Place (2006) 1.04
The use of typhoid vaccines in Asia: the DOMI experience. Clin Infect Dis (2007) 1.03
Classification of hybrid and altered Vibrio cholerae strains by CTX prophage and RS1 element structure. J Microbiol (2010) 1.03
Haemophilus influenzae type B meningitis among children in Hanoi, Vietnam: epidemiologic patterns and estimates of H. Influenzae type B disease burden. Am J Trop Med Hyg (2006) 1.03
Oral cholera vaccines--a call for action. Indian J Med Res (2010) 1.02
Immunization against Japanese encephalitis in China: a policy analysis. Vaccine (2006) 1.02
Diarrhoea episodes and treatment-seeking behaviour in a slum area of North Jakarta, Indonesia. J Health Popul Nutr (2004) 1.02
Genetic diversity of El Tor strains of Vibrio cholerae O1 with hybrid traits isolated from Bangladesh and Mozambique. Int J Med Microbiol (2007) 1.01
Community participation in two vaccination trials in slums of Kolkata, India: a multi-level analysis. J Health Popul Nutr (2010) 1.01
Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan. Vaccine (2012) 1.00
Clinical and epidemiological features of typhoid fever in Pemba, Zanzibar: assessment of the performance of the WHO case definitions. PLoS One (2012) 1.00
A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community. J Health Popul Nutr (2004) 1.00
Spatial risk for gender-specific adult mortality in an area of southern China. Int J Health Geogr (2007) 0.99
Suppressive effect of zinc on antibody response to cholera toxin in children given the killed, B subunit-whole cell, oral cholera vaccine. Vaccine (2004) 0.98